Baseline Achievement of Lipid Goals and Usage of Lipid Medications in Patients With Diabetes Mellitus (from the Veterans Affairs Diabetes Trial)

American Journal of Cardiology

Volumn 98, Issue 1, 2006, Pages 63-65

  Meyers, Charles D ^a   McCarren, Madeline ^b   Wong, Nathan D ^c   Abraira, Carlos ^d   Duckworth, William C ^e   Kashyap, Moti L ^c  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; RESIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CALCULATION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION; TRIACYLGLYCEROL BLOOD LEVEL; VETERAN;

ANTILIPEMIC AGENTS; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 33745145442     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.061     Document Type: Article

References (13)

1. Abraira C., Duckworth W., McCarren M., Emanuele N., Arca D., Reda D., and Henderson W. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2. Veterans Affairs Diabetes Trial. J Diabetes Complications 17 (2003) 314-322
2. Standards of medical care in diabetes. Diabetes Care 28 (2005) S4-S36
3. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998) 837-853
4. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
5. Veterans Health Administration's clinical practice guidelines for the management of dyslipidemia in primary care. Available at: http://www.oqp.med.va.gov/cpg/DL/DL_GOL.htm. Accessed December 1, 2005.
6. Coon P., and Zulkowski K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care 25 (2002) 2224-2229
7. Fuke D., Hunt J., Siemienczuk J., Estoup M., Carroll M., Payne N., and Touchette D. Cholesterol management of patients with diabetes in a primary care practice-based research network. Am J Manag Care 10 (2004) 130-136
8. Jacobs M.J., Kleisli T., Pio J.R., Malik S., L'Italien G.J., Chen R.S., and Wong N.D. Prevalence and control of dyslipidemia among persons with diabetes in the United States. Diabetes Res Clin Pract 70 (2005) 263-269
9. Snow V., Aronson M.D., Hornbake E.R., Mottur-Pilson C., and Weiss K.B. Lipid control in the management of type 2 diabetes mellitus. a clinical practice guideline from the American College of Physicians. Ann Intern Med 140 (2004) 644-649
10. Verges B. Diabetic dyslipidaemia. insights for optimizing patient management. Curr Med Res Opin 21 suppl 1 (2005) S29-S40
11. Keech A., Simes R.J., Barter P., Best J., Scott R., Taskinen M.R., Forder P., Pillai A., Davis T., Glasziou P., et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study). randomised controlled trial. Lancet 366 (2005) 1849-1861
12. Rubins H.B., Robins S.J., Collins D., Nelson D.B., Elam M.B., Schaefer E.J., Faas F.H., and Anderson J.W. Diabetes, plasma insulin, and cardiovascular disease. subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT). Arch Intern Med 162 (2002) 2597-2604
13. Canner P.L., Furberg C.D., Terrin M.L., and McGovern M.E. Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project). Am J Cardiol 95 (2005) 254-257